Pulmonary vascular disease & thromboembolism

Endovascular mechanical thrombectomy vs. catheter-directed thrombolysis in pulmonary embolism: insights from the National Readmission Database

Eur Heart J Acute Cardiovasc CarePublished retrospective cohort study

Main finding · In-hospital mortalityResult — go to the resultOdds ratio 1.31 95% CI 1.01–1.68

Authors' conclusion

Endovascular CDT was associated with lower in-hospital mortality and major bleeding compared to MT in PE. As hospital procedural volume increased, both these outcomes improved, while difference in outcomes between MT and CDT reduced.

Study context

Population
Adults with a primary diagnosis of pulmonary embolism (PE) who underwent either mechanical thrombectomy (MT) or catheter-directed thrombolysis (CDT), 2021 National Readmission Database (NRD)after propensity-score matching
Participants
7,376 vs 7,355
Exposure
MT compared with CDT
  • MTn = 7,376
  • CDTn = 7,355reference
Outcome
In-hospital mortality
Methodological detailspropensity-score matching
  • Propensity-score matching

Main finding

As reported in the abstract

Odds ratio

1.31

95% CI 1.01–1.68

P = 0.04

By group

MTvs CDT
OR 1.31 (95% CI 1.01–1.68); P = 0.04

Observational data: associations, not effects.

Secondary outcomes

Post-discharge mortality

No significant differences

All-cause readmissions

Higher in the MT group

In-hospital mortality and major bleeding by hospital procedural volume (subgroup)

Higher hospital procedural volumes associated with lower in-hospital mortality and lower major bleeding rates in both MT and CDT

Safety

OutcomeMTCDTOR (95% CI)P value
Major bleedingHigher odds with MT6.3%3.6%1.79 (1.39–2.32)P < 0.001

Original publication

Endovascular mechanical thrombectomy vs. catheter-directed thrombolysis in pulmonary embolism: insights from the National Readmission Database. Eur Heart J Acute Cardiovasc Care. Published 23 August 2025. doi:10.1093/ehjacc/zuaf110

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.